HFD and obesity (8) or type 2 diabetes (11) are associated with upregulated ACOT1 abundance, suggesting ACOT1 may have a role in the development of obesity and, thus, may be a potential therapeutic target. This evidence concerns the gene ACOT1 and type 2 diabetes mellitus.